Spotlight Growth
No Result
View All Result
Friday, February 3, 2023
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Cannabis

Advantis Corporation (OTC Pink: ADVT) Rallies 22% After Beginning Cannabis Edible Packaging

by admin
September 24, 2018
in Cannabis
0
Advantis Corporation Cannabis Edibles Packaging Starts News OTC Markets

Advantis Corporation Cannabis Edibles Packaging Starts News OTC Markets

Advantis Corporation (OTC Pink: ADVT) is engaged within the development of innovative and proprietary products that contain and supply solutions to the medical, research, and pharmaceutical industries. Shares of the innovative product company rallied 22% on Monday, September 24, 2018. Advantis Corporation saw volume of 2.15 million shares or dollar volume of $47,095, exchanged hands during Monday’s trading.

Shares of Advantis Corporation gained on Monday, after the company announced that it has entered into an agreement to package cannabis edibles through the see-through Amster-Can packaging. The company will start packaging gummy candies to launch, after entering into an agreement with Herb N’ Works. The company notes that its packaging is capable of holding mints, brownies, chocolates, and other cannabis-infused edibles. The edibles are said to contain either THC, CBD, or both. Here is the full press release detailing of the edible packaging agreement:

Advantis Corporation Press Release:

NEWPORT BEACH, CA , Sept. 24, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced today that it has just reached an agreement to package edibles in the new see-through Amster- Can packaging. Gummy candies will be the first of several edibles to be packaged by Advantis.

According to Advantis CEO, Darren Cherry, the company has been working with its partners to establish edible and extract packaging for some time. “We are thrilled to finally debut one of the most popular cannabis-infused edibles in the marketplace,” Cherry said. “This is just the beginning. There will be a handful of edibles that fit perfectly within our packaging wheelhouse; Mints, brownies, chocolates, and other infused items; this development will allow us to enter the growing edible business with a ready-made distribution channel.” Cherry alluded to the existing product partners that distribute the products that Advantis packages for them. “We are at an exciting place in our business cycle right now. Each new development like this just adds to our bottom line,” Cherry concluded.

Cherry exemplified this point with the coming debut of sublingual tabs. The sublingual tabs ensure exact dosing for those that need a specific prescribed amount to ensure maximum efficacy for a given ailment. “We spend a lot of energy on developing these products, and we expect this to expand rapidly. We already have our partner in Oregon poised to begin distribution as soon as we receive the first full batch of the product.” The sublingual tabs can be manufactured with CBD, THC, or a combination of both. “I am very excited for these to hit the market, and even more excited for what’s coming before the end of the year.” Cherry related that our Las Vegas partner will soon be ramping up production and expects Oregon to increase production when they have the newest packaging machine in place.

The company has been working on increasing its social media presence to market themselves more consistently and effectively. “We’re still working with Herb N‘ Works, but in the mean-time we are adding videos and information through our Facebook and Instagram pages so customers and investors can keep a sharper eye on what is happening day to day,” Cherry explained. “While we add more efficient machines to our partners in Oregon and Nevada, our California presence is increasing rapidly. Social media will provide us a more firmly established footprint, and ultimately contribute to our growing revenue base since more eyes will be on us.” Cherry concluded his comments by saying, “The Pet Division is on track for its launch and distribution channels are currently being negotiated with. This may take some time to establish our agreements, as we are negotiating with existing well-known pet food distribution companies. The Pet Division will provide a wealth of new opportunities as we evolve.” Cherry added that the Orange County location has finished phase one and will likely be up and running before the Los Angeles location.

Advantis wishes to thank Investors Hangout for mentioning the company in their podcast.

Links to Advantis websites can be found at advantiscorp.com, rosin6.com, elixicure.com, and amstercan.com

About Advantis Corporation

Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes partnerships with businesses that develop and sell proprietary pain management, and consumer products and services.

Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.

Tags: acquisitionADVTbiopharmaceuticalsbiotechcannabiscannabis ediblescommon stockediblesedibles packagingemerging growthinvestinginvestmentmarijuana ediblesmarijuana stocksmedicalmedical cannabismedical marijuanamicrocap stocksMJ stocksnewsotc marketsOTC Pinkpharmaceuticalspot stockspublic companysalesservicessmall cap companiessmall cap stockssmall capsSpotlight GrowthSpotlight Growth Stocksstock marketstockstrading
  • Trending
  • Comments
  • Latest
Asure Software NASDAQ ASUR Human Capital Management HCM Industry Spotlight Growth

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

September 27, 2022
OLB Group NASDAQ OLB Cuentas NASDAQ CUEN Partnership Fintech Spotlight Growth

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

October 6, 2022
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Elys Game Technology Corp NASDAQ ELYS Completes Acquisition of Engage IT Services Spotlight Growth

Elys Game Technology Corp (NASDAQ: ELYS) Completes Acquisition of Engage IT Services, a Software Engineering and IT Development Company

February 2, 2023
Tenax Therapeutics NASDAQ TENX US Patent Levosimendan PH-HFpEF Spotlight Growth

Tenax Therapeutics (NASDAQ: TENX) Granted U.S. Patent for IV Levosimendan for Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

February 2, 2023
Versus Systems NASDAQ VS Resolve Debt Partner AI Gamification Consumer Debt Spotlight Growth

Versus Systems (NASDAQ: VS) and Resolve Debt Partner to Integrated Generative AI and Gamification to Customer Payments and Credit Markets

February 1, 2023
Finding the Most Accurate Technical Analysis Indicator Spotlight Growth

Finding the Most Accurate Technical Analysis Indicator

January 31, 2023
ADVERTISEMENT

Recent News

Elys Game Technology Corp NASDAQ ELYS Completes Acquisition of Engage IT Services Spotlight Growth

Elys Game Technology Corp (NASDAQ: ELYS) Completes Acquisition of Engage IT Services, a Software Engineering and IT Development Company

February 2, 2023
Tenax Therapeutics NASDAQ TENX US Patent Levosimendan PH-HFpEF Spotlight Growth

Tenax Therapeutics (NASDAQ: TENX) Granted U.S. Patent for IV Levosimendan for Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

February 2, 2023

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Education
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested